Browsing by Title

Now showing items 97303-97322 of 129008

S100B and LDH as early prognostic markers for response and overall survival in melanoma patients treated with anti-PD-1 or combined anti-PD-1 plus anti-CTLA-4 antibodies

Wagner, Nikolaus B.; Forschner, Andrea Lydia; Leiter-Stöppke, Ulrike; Garbe, Claus; Eigentler, Thomas (2018)
S100B and LDH as parameters to monitor the clinical course of patients with advanced melanoma treated with Vemurafenib

Abusaif, Sail Nawaf Rashid (2016)
S100B and LDH as parameters to monitor the clinical course of patients with advanced melanoma treated with Vemurafenib

Abusaif, Sail Nawaf Rashid (2016-12)

Vemurafenib is a highly efficient BRAF inhibitor for metastatic melanoma patients carrying the V600 mutation. Progression free survival is prolonged to approximately 6 months and 50 to 80% of the patients show objective ...
S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-alpha pathway

Maetzler, Walter; Lang, Johannes Dominik; Schulte, Claudia; Synofzik, Matthis; Berg, Daniela (2012)
S100B Serum Level is Independent of Moderate Alcohol Intoxication

Stollhof, Laura (2020)
S1‐Leitlinie Tinea capitis

Schaller, Martin (2020)
S2k guideline basal cell carcinoma of the skin (update 2023)

Klumpp, Bernhard (2024)
S2k guideline on diagnosis and treatment of atopic dermatitis - short version

Röcken, Martin (2016)
S2k guideline: Rosacea

Schaller, Martin; Zierhut, Manfred (2022)
S2k Guidelines for Cutaneous Basal Cell Carcinoma - Part 1 : Epidemiology, Genetics and Diagnosis

Klumpp, Bernhard (2019)
S2k Guidelines for Cutaneous Basal Cell Carcinoma - Part 2: Treatment, Prevention and Follow-up

Klumpp, Bernhard (2019)
S2k Kurzleitlinie – Plattenepithelkarzinom der Haut

Breuninger, Helmut; Eigentler, Thomas; Garbe, Claus (2013)
S2k Leitlinie Autoimmune Lebererkrankungen AWMF-Reg. Nr. 021-27

Klein, Reinhild (2017)
S2k-Leitlinie (Kurzfassung): Management der Großgefäßvaskulitiden

Henes, Jörg Christoph (2020)
S2k-Leitlinie Gastrointestinale Infektionen und Morbus Whipple[1]

Berg, Christoph Peter (2015)
S2k-Leitlinie Humangenetische Diagnostik und Genetische Beratung

Dufke, Andreas (2018)
S2k-Leitlinie: Management der Großgefäßvaskulitiden

Henes, Jörg Christoph (2020)
S2S-Net: Addressing the Domain Gap of Heterogeneous Sensor Systems in LiDAR-Based Collective Perception

Teufel, Sven; Gamerdinger, Jörg; Bringmann, Oliver (2025-04-24)
S3 guideline actinic keratosis and cutaneous squamous cell carcinoma- update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care

Amaral, Teresa; Breuninger, Helmut; Kofler, Lukas; Pfannenberg, Christina; Garbe, Claus; Leiter-Stöppke, Ulrike (2023)
S3 guideline actinic keratosis and cutaneous squamous cell carcinoma - update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention

Amaral, Teresa; Breuninger, Helmut; Kofler, Lukas; Pfannenberg, Christina; Garbe, Claus; Leiter-Stöppke, Ulrike (2023)

Now showing items 97303-97322 of 129008

Submit

Browse

All of DSpace

Browsing by Title

Browsing by Title

Browse

All of DSpace

My Account

Hilfe & Infos